Biomarkers Involved in the Pathogenesis of Hemophilic Arthropathy
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25189897 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Oana Viola Badulescu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathophysiology, University of Medicine and Pharmacy Grigore T. Popa, 700115 Iasi, Romania. Hauptthemen laut MEDLINE: Biomarkers, Hemophilia A. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Hemophilia, which is a rare disease, results from congenital deficiencies of coagulation factors VIII and IX, respectively, leading to spontaneous bleeding into joints, resulting in hemophilic arthropathy (HA). HA involves complex processes, including synovial proliferation, angiogenesis, and tissue remodeling. Despite ongoing research, factors contributing to HA progression, especially in adults with severe HA experiencing joint pain, remain unclear. Blood markers, particularly collagen-related ones, have been explored to assess joint health in hemophilia. For example, markers like CTX-I and CTX-II reflect bone and cartilage turnover, respectively. Studies indicate elevated levels of certain markers post-bleeding episodes, suggesting joint health changes. However, longitudinal studies on collagen turnover and basement membrane or endothelial cell markers in relation to joint outcomes, particularly during painful episodes, are scarce. Given the role of the CX3CL1/CX3XR1 axis in arthritis, other studies investigate its involvement in HA. The importance of different inflammatory and bone damage biomarkers should be assessed, alongside articular cartilage and synovial membrane morphology, aiming to enhance understanding of hemophilic arthropathy progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathophysiology, University of Medicine and Pharmacy Grigore T. Popa, 700115 Iasi, Romania.
- Department of Surgical Sciences, University of Medicine and Pharmacy Grigore T. Popa, 700115 Iasi, Romania.
- Department of Internal Medicine, University of Medicine and Pharmacy Grigore T. Popa, 700115 Iasi, Romania.
- Department of Pediatry, University of Medicine and Pharmacy Grigore T. Popa, 700115 Iasi, Romania.
ORCID-Profile: Oana Viola Badulescu, Minerva Codruta Badescu, Manuela Ciocoiu, Carmen Elena Plesoianu, Otilia Elena Frasinariu
Zitieren
APA
Badulescu, O. V., Scripcariu, D. V., Badescu, M. C., Ciocoiu, M., Vladeanu, M. C., Plesoianu, C. E., Bojan, A., Iliescu-Halitchi, D., Tudor, R., Huzum, B., Frasinariu, O. E., & Bararu-Bojan, I. (2024). Biomarkers Involved in the Pathogenesis of Hemophilic Arthropathy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25189897
Vancouver
Badulescu OV, Scripcariu DV, Badescu MC, Ciocoiu M, Vladeanu MC, Plesoianu CE, et al. Biomarkers Involved in the Pathogenesis of Hemophilic Arthropathy. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25189897
BibTeX
@article{Badulescu2024,
author = {Badulescu, Oana Viola and Scripcariu, Dragos-Viorel and Badescu, Minerva Codruta and Ciocoiu, Manuela and Vladeanu, Maria Cristina and Plesoianu, Carmen Elena and Bojan, Andrei and Iliescu-Halitchi, Dan and Tudor, Razvan and Huzum, Bogdan and Frasinariu, Otilia Elena and Bararu-Bojan, Iris},
title = {Biomarkers Involved in the Pathogenesis of Hemophilic Arthropathy},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25189897}
}
EUVIMED